IRON Stock Summary and Trading Ideas (Disc Medicine | NASDAQ:IRON)

Disc Medicine Inc is a clinical-stage biopharmaceutical company that is dedicated to transforming the lives of patients with hematologic disorders. The company is building a portfolio of inventive therapeutic candidates that affect fundamental pathways of red blood cell biology. Disc Medicine is committed to developing treatments that empower and bring hope to the many patients who suffer from hematologic disease. The Company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis.

Disc Medicine trades on the NASDAQ stock market under the symbol IRON.

As of April 24, 2024, IRON stock price climbed to $27.30 with 357,337 million shares trading.

IRON has a beta of 1.85, meaning it tends to be more sensitive to market movements. IRON has a correlation of 0.05 to the broad based SPY ETF.

IRON has a market cap of $673.79 million. This is considered a Small Cap stock.

The top ETF exchange traded funds that IRON belongs to (by Net Assets): VTI, XBI, VXF, IWM, VHT.

IRON has underperformed the market in the last year with a price return of -12.9% while the SPY ETF gained +24.2%. IRON has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -58.6% and -14.9%, respectively, while the SPY returned +4.6% and -2.7%, respectively.

IRON support price is $25.78 and resistance is $28.22 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that IRON stock will trade within this expected range on the day.